204 related articles for article (PubMed ID: 30218751)
1. MAN1B1 is associated with poor prognosis and modulates proliferation and apoptosis in bladder cancer.
Wang HF; Wu JH; Gai JW; Yang SQ; Ma QT; Ma HS; Feng Q
Gene; 2018 Dec; 679():314-319. PubMed ID: 30218751
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of TNFRSF14 indicates good prognosis and inhibits bladder cancer proliferation by promoting apoptosis.
Zhu YD; Lu MY
Mol Med Rep; 2018 Sep; 18(3):3403-3410. PubMed ID: 30066919
[TBL] [Abstract][Full Text] [Related]
3. High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer.
Li Q; Li C; Chen J; Liu P; Cui Y; Zhou X; Li H; Zu X
Urol Oncol; 2018 Jun; 36(6):310.e15-310.e22. PubMed ID: 29605462
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Karyopherin Subunit alpha 2 (KPNA2) Predicts Unfavorable Prognosis and Promotes Bladder Cancer Tumorigenicity via the P53 Pathway.
Shi C; Sun L; Liu S; Zhang E; Song Y
Med Sci Monit; 2020 Mar; 26():e921087. PubMed ID: 32147666
[TBL] [Abstract][Full Text] [Related]
5. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling.
Zhang J; Wei J; Lu J; Tong Z; Liao B; Yu B; Zheng F; Huang X; Chen Z; Fang Y; Li B; Chen W; Xie D; Luo J
Carcinogenesis; 2013 Oct; 34(10):2401-8. PubMed ID: 23722651
[TBL] [Abstract][Full Text] [Related]
7. Thyrotroph embryonic factor is downregulated in bladder cancer and suppresses proliferation and tumorigenesis via the AKT/FOXOs signalling pathway.
Yang J; Wang B; Chen H; Chen X; Li J; Chen Y; Yuan D; Zheng S
Cell Prolif; 2019 Mar; 52(2):e12560. PubMed ID: 30515906
[TBL] [Abstract][Full Text] [Related]
8. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling.
Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D
Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway.
Liang Z; Wang X; Xu X; Xie B; Ji A; Meng S; Li S; Zhu Y; Wu J; Hu Z; Lin Y; Zheng X; Xie L; Liu B
Mol Cancer; 2017 May; 16(1):96. PubMed ID: 28549468
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
Jin X; Jiao X; Jiao J; Zhang T; Cui B
Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
[TBL] [Abstract][Full Text] [Related]
11. Opa interacting protein 5 acts as an oncogene in bladder cancer.
He X; Hou J; Ping J; Wen D; He J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2221-2233. PubMed ID: 28752236
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of DUXAP10 inhibits proliferation and promotes apoptosis in bladder cancer cells via PI3K/Akt/mTOR signaling pathway.
Lv XY; Ma L; Chen JF; Yu R; Li Y; Yan ZJ; Cheng Y; Ma Q
Int J Oncol; 2018 Jan; 52(1):288-294. PubMed ID: 29115412
[TBL] [Abstract][Full Text] [Related]
13. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
15. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
[TBL] [Abstract][Full Text] [Related]
16. CCDC34 is up-regulated in bladder cancer and regulates bladder cancer cell proliferation, apoptosis and migration.
Gong Y; Qiu W; Ning X; Yang X; Liu L; Wang Z; Lin J; Li X; Guo Y
Oncotarget; 2015 Sep; 6(28):25856-67. PubMed ID: 26312564
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.
Liu Y; Wang H; Zhong J; Wu C; Yang G; Zhong Y; Zhang J; Tang A
BMC Cancer; 2018 Jun; 18(1):642. PubMed ID: 29880037
[TBL] [Abstract][Full Text] [Related]
18. MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.
Yao Y; Hu J; Shen Z; Yao R; Liu S; Li Y; Cong H; Wang X; Qiu W; Yue L
J Cell Mol Med; 2015 Apr; 19(4):760-9. PubMed ID: 25639535
[TBL] [Abstract][Full Text] [Related]
19. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
[TBL] [Abstract][Full Text] [Related]
20. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
